Improved long term survival of patients with metastatic nonseminomatous testicular germ cell carcinoma in relation to prognostic classification systems during the cisplatin era

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Cancer

• Publication date

  2001-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/1097-0142(20010401)91:7<1304::AID-CNCR1133>3.0.CO;2-APMID 11283931
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Geographic clustering of testicular cancer incidence in the northern part of The Netherlands

  1999cited by this paper
• Impact of the treating institution on survival of patients with "poor-prognosis" metastatic nonseminoma. European Organization for Research and Treatment of Cancer Genito-Urinary Tract Cancer Collaborative Group and the Medical Research Council Testicular Cancer Working Party.

  1999cited by this paper
• Does size matter? Association between number of patients treated and patient outcome in metastatic testicular cancer.

  1999cited by this paper
• First-line high-dose chemotherapy compared with standard-dose PEB/VIP chemotherapy in patients with advanced germ cell tumors: A multivariate and matched-pair analysis.

  1999cited by this paper
• The National Cancer Data Base report on patterns of care for testicular carcinoma, 1985–1996

  1999cited by this paper
• The changing distribution of stage in nonseminomatous testicular germ cell tumours, from 1977 to 1996

  1999cited by this paper
• Markers and management of germ-cell tumours of the testes.

  1998cited by this paper
• Improved survival for patients with testicular cancer in Europe since 1978. EUROCARE Working Group.

  1998cited by this paper
• Current concepts about testicular cancer.

  1998cited by this paper
• Mature teratoma identified after postchemotherapy surgery in patients with disseminated nonseminomatous testicular germ cell tumors

  1998cited by this paper
• Mature teratoma identified after postchemotherapy surgery in patients with disseminated nonseminomatous testicular germ cell tumors: a plea for an aggressive surgical approach.

  1998cited by this paper
• Four cycles of BEP vs four cycles of VIP in patients with intermediate-prognosis metastatic testicular non-seminoma: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group. European Organization for Research and Treatment of Cancer.

  1998cited by this paper
• Advanced testicular cancer: update for urologists.

  1998cited by this paper
• Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: a Randomized Medical Research Council/European Organization for Research and Treatment of Cancer study.

  1998cited by this paper
• Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial.

  1997cited by this paper
• Late relapse of germ cell tumors after cisplatin-based chemotherapy.

  1997cited by this paper
• Testicular germ-cell cancer.

  1997cited by this paper
• Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group.

  1997cited by this paper
• International germ cell consensus classification: A prognostic factor-erased staging system for metastatic germ cell cancers

  1997cited by this paper
• Advances in the management of metastatic non-seminomatous germ cell tumours during the cisplatin era: a single-institution experience.

  1996cited by this paper
• Four cycles of BEP versus an alternating regime of PVB and BEP in patients with poor-prognosis metastatic testicular non-seminoma; a randomised study of the EORTC Genitourinary Tract Cancer Cooperative Group.

  1995cited by this paper
• The sexual sequelae of testicular cancer.

  1995cited by this paper
• Testicular cancer treated in a minor general oncology department.

  1995cited by this paper
• Non-specialist units, clinical trials and survival from testicular cancer.

  1995cited by this paper
• Late relapse of testicular cancer.

  1995cited by this paper
• Management of malignant teratoma: does referral to a specialist unit matter?

  1993cited by this paper
• Prognosis after resection of residual masses following chemotherapy for metastatic nonseminomatous testicular cancer: a multivariate analysis.

  1993cited by this paper
• The Second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumors. Medical Research Council Testicular Tumour Working Party.

  1992cited by this paper
• Modulation of fluorouracil toxicity with uridine.

  1992cited by this paper
• Current perspectives on the role of adjunctive surgery in combined modality treatment for patients with germ cell tumors.

  1992cited by this paper
• Prognostic factors in unselected patients with nonseminomatous metastatic testicular cancer: a multicenter experience.

  1991cited by this paper
• Long-term outcome in patients with germ cell tumours treated with POMB/ACE chemotherapy: comparison of commonly used classification systems of good and poor prognosis.

  1989cited by this paper
• Stage migration and the increasing proportion of complete responders in patients with advanced germ cell tumors.

  1988cited by this paper
• Comparison of criteria for assigning germ cell tumor patients to "good risk" and "poor risk" studies.

  1988cited by this paper
• Multivariate analysis of prognostic factors in patients with disseminated nonseminomatous testicular cancer: results from a European Organization for Research on Treatment of Cancer Multiinstitutional Phase III Study.

  1987cited by this paper
• Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide.

  1987cited by this paper
• Prognostic factors for favorable outcome in disseminated germ cell tumors.

  1986cited by this paper
• Evidence that a novel rotavirus-like agent of rats can cause gastroenteritis in man.

  1985cited by this paper
• Prognostic factors in advanced non-seminomatous germ-cell testicular tumours: results of a multicentre study

  1985cited by this paper
• The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer.

  1985cited by this paper
• The role of maintenance therapy in disseminated testicular cancer.

  1981cited by this paper
• Combination chemotherapy with cis-diammine-dichloro-platinum, vinblastine, and bleomycin in advanced testicular non-seminoma.

  1979cited by this paper
• Combined management of malignant teratoma of the testis.

  1979cited by this paper
• Letter: Radioimmunoassay of apo-L.D.L.

  1974cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper
• The National.

  1892cited by this paper

• IGCCCG-Fehlklassifikation (International Germ Cell Consensus Classification) durch zeitlich inkorrekte Interpretation der Serumkonzentration der Tumormarker bei metastasierten testikulären Keimzelltumoren

  2021cites this paper
• Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium

  2021influential citation
• IGCCCG-Fehlklassifikation ( International Germ Cell Consensus Classification ) durch zeitlich inkorrekte Interpretation

  2021cites this paper
• Posterior retroperitoneoscopic resection of recurrent nonseminomatous tumor mass: a case report of the surgical procedure

  2020cites this paper
• Laparoscopic Resection of Residual Retroperitoneal Tumor Mass in Advanced Nonseminomatous Testicular Germ Cell Tumors; a Feasible and Safe Oncological Procedure

  2019cites this paper
• Effects of Single Nucleotide Polymorphism Ala270Ser (rs316019) on the Function and Regulation of hOCT2

  2019cites this paper
• Impact of Teratoma on the Cumulative Incidence of Disease-Related Death in Patients With Advanced Germ Cell Tumors.

  2019cites this paper
• Testicular cancer: diagnostic and surgical strategies to improve outcome

  2018cites this paper
• A Suggested Prognostic Reclassification of Intermediate and Poor‐Risk Nonseminomatous Germ Cell Tumors

  2017cites this paper
• 2 Quality of life of survivors of testicular germ cell cancer : a review of the literatureJoke

  2017cites this paper
• Dimethyl sulfoxide induces chemotherapeutic resistance in the treatment of testicular embryonal carcinomas.

  2015cites this paper
• Prognostic Factors at Initial Presentation and in Recurrent Disease

  2015cites this paper
• Testicular cancer – response adapted treatment, prognostic markers and survivorship issues

  2015cites this paper
• Increased sensitivity of human lung adenocarcinoma cells to cisplatin associated with downregulated contactin-1.

  2015cites this paper
• Delay in Diagnosis of Testicular Cancer; A Need for Awareness Programs

  2015cites this paper
• Editorial Comment from Dr Beyer to Identification of a subgroup with worse prognosis among patients with poor‐risk testicular germ cell tumor

  2015cites this paper
• Validation of Surveillance, Epidemiology, and End Results TNM staging for testicular germ cell tumor.

  2014cites this paper
• Is there an intermediate-risk non-seminoma? long-term treatment results from a single center.

  2014cites this paper
• Clinical Treatment of Extracranial Pediatric Germ Cell Tumors

  2014cites this paper
• Effect of amine and carboxyl functionalization of sub-micrometric MCM-41 spheres on controlled release of cisplatin

  2013cites this paper
• During twenty years of Cisplatin-based therapy the face of nonseminomatous testicular germ cell tumors is still changing: an evaluation of presentation, management, predictive factors and survival.

  2013cites this paper
• Alpha-fetoprotein surge following high-dose chemotherapy in germ cell tumours

  2013cites this paper
• Health-related quality of life in young men with testicular cancer: validation of the Cancer Assessment for Young Adults (CAYA)

  2013cites this paper
• Molecular tools for companion diagnostics.

  2012cites this paper
• Therapeutic potential of SOX2 inhibition for embryonal carcinoma.

  2012cites this paper
• Advances in the Treatment of Testicular Cancer

  2012cites this paper
• Ovarian immature teratoma: treatment and outcome in a single institutional cohort.

  2011cites this paper
• Population-based study of treatment guided by tumor marker decline in patients with metastatic nonseminomatous germ cell tumor: a report from the Swedish-Norwegian Testicular Cancer Group.

  2011cites this paper
• Oncology patient-reported claims: maximising the chance for success

  2011cites this paper
• Laparoscopic resection of a residual retroperitoneal tumor mass of nonseminomatous testicular germ cell tumors

  2011cites this paper
• Treatment of Patients with Stage II A/B and Advanced Nonseminomatous Germ Cell Tumors

  2011cites this paper
• Sexual function, depressive symptoms and marital status in nonseminoma testicular cancer patients: a longitudinal study

  2010cites this paper
• FDG-PET probe-guided surgery for recurrent retroperitoneal testicular tumor recurrences.

  2010cites this paper
• Cáncer de testículo

  2009cites this paper
• The BMT Data Book

  2009cites this paper
• PCN137 ONCOLOGY PATIENT-REPORTED CLAIMS: MAXIMISING THE CHANCE FOR SUCCESS

  2009cites this paper
• The management of non-seminomatous germ-cell tumours patients with viable malignancy at the time of RPLND.

  2008cites this paper
• European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I.

  2008cites this paper
• Surviving testicular cancer

  2008cites this paper
• Clinical and genetic aspects of testicular germ cell tumours

  2008cites this paper
• Pharmacotherapy of relapsed metastatic testicular cancer

  2008cites this paper
• Survival from testicular cancer in England and Wales up to 2001

  2008cites this paper
• Application of the adult International Germ Cell Classification System to pediatric malignant non‐seminomatous germ cell tumors: A report from the Children's Oncology Group

  2008cites this paper
• European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II.

  2008cites this paper
• Evidence-based pragmatic guidelines for the follow-up of testicular cancer: optimising the detection of relapse

  2008cites this paper
• chapter 7 sexual function, depressive symptoms and marital status in testicular cancer patients: a longitudinal study

  2008cites this paper
• Pharmacotherapy of relapsed metastatic testicular cancer.

  2008cites this paper
• Brain metastasis from non-seminomatous germ cell tumor of the testis

  2007cites this paper
• Utility of single versus tandem autotransplants for advanced testes/germ cell cancer: a center for international blood and marrow transplant research (CIBMTR) analysis.

  2007cites this paper
• Long‐term results of first‐line sequential high‐dose carboplatin, etoposide and ifosfamide chemotherapy with peripheral blood stem cell support for patients with advanced testicular germ cell tumor

  2007cites this paper
• Phase I/II study of sequential dose-intensified ifosfamide, cisplatin, and etoposide plus paclitaxel as induction chemotherapy for poor prognosis germ cell tumors by the German Testicular Cancer Study Group.

  2007cites this paper
• Stage I seminoma and carboplatin risks.

  2007cites this paper
• Methodological Aspects of Prognostic Classifications: Applications in Testicular Cancer

  2007cites this paper
• Genetic predisposition to testicular cancer

  2007cites this paper
• Quality of Life of Testicular Cancer Survivors

  2006cites this paper
• Eigene Erfahrungen zur Hochdosischemotherapie mit autologer Stammzelltransplantation bei fortgeschrittenen testikulären Keimzelltumoren mit schlechter Prognose

  2006cites this paper
• Facilitators and obstacles to sperm banking in young men receiving gonadotoxic chemotherapy for cancer: the perspective of survivors and health care professionals.

  2006cites this paper
• Recent advances in management of patients with platinum‐refractory testicular germ cell tumors

  2006cites this paper
• Preoperative workup and postoperative surveillance for patients undergoing pulmonary metastasectomy.

  2006cites this paper
• Testicular germ-cell cancer.

  2006cites this paper
• Self-esteem, social support, and mental health in survivors of testicular cancer: a comparison based on relationship status.

  2006cites this paper
• Therapeutic Drug Monitoring for Dose Individualization of Cisplatin in Testicular Cancer Patients Based Upon Total Platinum Measurement in Plasma

  2006cites this paper
• Survival estimates of a prognostic classification depended more on year of treatment than on imputation of missing values.

  2006cites this paper
• Survival of non-seminomatous germ cell cancer patients according to the IGCC classification: An update based on meta-analysis.

  2006cites this paper
• Testicular cancer: a longitudinal pilot study on stress response symptoms and quality of life in couples before and after chemotherapy

  2006cites this paper
• Significance of elevated preoperative α‐fetoprotein in postchemotherapy residual tumor resection for the disseminated germ cell tumors

  2006cites this paper
• Recent advances in the treatment of testicular cancer

  2005cites this paper
• Intensive induction chemotherapy with C-BOP/BEP for intermediate- and poor-risk metastatic germ cell tumours (EORTC trial 30948)

  2005cites this paper
• FDG-PET in the management of germ cell tumor.

  2005cites this paper
• Salvage, dose intense and high-dose chemotherapy for the treatment of poor prognosis or recurrent germ cell tumours.

  2005cites this paper
• Outcome and prognostic factors in ovarian germ cell malignancies.

  2005cites this paper
• Secondary leukemia after first-line high-dose chemotherapy for patients with advanced germ cell cancer

  2005influential citation
• Zur Problematik der Spätrezidive von Hodentumoren

  2005cites this paper
• The management of poor-prognosis, non-seminomatous germ-cell tumours.

  2005cites this paper
• Guidelines on testicular cancer.

  2005cites this paper
• C?ncer de test?culo

  2005cites this paper
• Male sexuality after cancer treatment--needs for information and support: testicular cancer compared to malignant lymphoma.

  2004cites this paper
• Advances in the management of non‐seminomatous germ cell tumors during the cisplatin era: A single‐institution experience

  2004cites this paper
• European Association of Urology GUIDELINES ON TESTICULAR CANCER

  2004cites this paper
• The management and survival of patients with advanced germ-cell tumours: improving outcome in intermediate and poor prognosis patients.

  2004cites this paper
• European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG).

  2004cites this paper
• Niere und Harnwege

  2004cites this paper
• Genetic predisposition to testicular germ-cell tumours.

  2004cites this paper
• Survival of patients with nonseminomatous germ cell cancer: a review of the IGCC classification by Cox regression and recursive partitioning

  2004cites this paper
• testicular germ cell cancer : a review of the literature

  2004cites this paper
• Identifying subgroups among poor prognosis patients with nonseminomatous germ cell cancer by tree modelling: a validation study.

  2004cites this paper
• Quality of life of survivors of testicular germ cell cancer: a review of the literature

  2004cites this paper
• Long-term follow-up of patients with poor prognosis germ cell tumor treated with early high-dose chemotherapy with hematopoietic progenitor cell support: a single-center experience

  2004cites this paper
• Predicting factors for collection of peripheral blood stem cells in patients with advanced germ cell tumors after cisplatin-based combination chemotherapy.

  2003cites this paper
• Laboratory markers and germ cell tumors.

  2003cites this paper
• Improved prognosis of patients with intermediate‐ and poor‐risk nonseminomatous germ cell tumours by optimizing combined treatment

  2003cites this paper
• Non–Germ Cell Malignancy in Residual or Recurrent Mass After Chemotherapy for Nonseminomatous Testicular Germ Cell Tumor

  2003cites this paper
• Lung resistance-related protein as a predictor of clinical outcome in advanced testicular germ-cell tumours

  2003cites this paper
• Sexual health after treatment for testicular cancer: a one year follow-up 1

  2003cites this paper
• Long-term cryopreservation of peripheral blood stem cells in patients with advanced germ cell tumors using the dump-freezing method at -80 degrees C.

  2003cites this paper
• Laboratory Markers and Germ Cell Tumors

  2003cites this paper
• Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.

  2003cites this paper
• Chemotherapie bei Keimzelltumoren mit intermediärer und schlechter Prognose

  2003cites this paper
• Non–Germ Cell Malignancy in Residual or Recurrent Mass After Chemotherapy for Nonseminomatous Testicular Germ Cell Tumor

  2003cites this paper
• Therapie von metastasierten Keimzelltumoren bei Patienten mit "Good-prognosis"- Kriterien

  2003cites this paper